Skip to main content
. 2016 Aug 2;11(8):e0160192. doi: 10.1371/journal.pone.0160192

Table 2. Estimated effects of measures of peripheral blood total or integrated HIV-1 DNA on anti-HIV antibody responsesa.

Total HIV-1 DNA
rtPCR (CD4) ddPCR (PBMC) ddPCR (rCD4)
(N = 46) (N = 20) (N = 11)
Antibody Fold-changeb Pc Fold-change P Fold-change P
GP120 1.02 (0.92, 1.12) 0.75 1.06 (0.93, 1.2) 0.35 1.08 (0.91, 1.29) 0.35
GP41 1.00 (0.96, 1.03) 0.88 1.02 (0.99, 1.06) 0.16 0.99 (0.93, 1.04) 0.57
RT 0.99 (0.93, 1.06) 0.84 1.05 (0.98, 1.12) 0.13 1.01 (0.92, 1.10) 0.89
INT 1.05 (0.92, 1.19) 0.47 1.16 (0.98, 1.37) 0.074 1.14 (0.96, 1.34) 0.12
PR 0.94 (0.78, 1.14) 0.51 1.37 (0.97, 1.95) 0.070 1.28 (0.85, 1.93) 0.21
MA 0.95 (0.79, 1.14) 0.60 0.90 (0.68, 1.19) 0.46 0.92 (0.68, 1.25) 0.56
CA 0.92 (0.81, 1.04) 0.18 0.89 (0.67, 1.19) 0.42 0.84 (0.63, 1.12) 0.20
Integrated HIV-1DNA
Alu-LTR PCR (CD4) Alu-LTR PCR (PBMC) Alu-gag PCR (rCD4)
(N = 46) (N = 12) (N = 10)
Antibody Fold-changeb Pc Fold-change P Fold-change P
GP120 1.07 (0.96, 1.19) 0.24 1.03 (0.78, 1.36) 0.83 0.88 (0.59, 1.30) 0.47
GP41 1.00 (0.96, 1.04) 0.98 1.00 (0.95, 1.06) 0.97 0.98 (0.91, 1.05) 0.55
RT 1.04 (0.97, 1.12) 0.23 1.04 (0.90, 1.20) 0.52 0.98 (0.79, 1.20) 0.79
INT 1.02 (0.88, 1.18) 0.83 0.98 (0.66, 1.46) 0.90 0.72 (0.40, 1.32) 0.25
PR 1.19 (0.95, 1.47) 0.12 1.46 (0.63, 3.40) 0.34 0.89 (0.24, 3.29) 0.84
MA 1.11 (0.89, 1.37) 0.34 0.68 (0.39, 1.19) 0.16 0.35 (0.20, 0.64) 0.003
CA 1.03 (0.88, 1.20) 0.70 0.77 (0.45, 1.32) 0.30 0.49 (0.24, 1.01) 0.053

Abbreviations: GP120 = envelope glycoprotein 120; GP41 = envelope glycoprotein 41; RT = reverse transcriptase; INT = integrase; PR = protease; MA = matrix; CA = capsid; rtPCR = reverse transcriptase polymerase chain reaction (PCR); LTR = long terminal repeat; Gag = HIV-1 Gag protein; ddPCR = droplet digital PCR; Alu PCR = PCR using a primer in an Alu element to detect integrated HIV-1 DNA; rCD4 = resting CD4+ T cells; PBMC = peripheral blood mononuclear cells. Associations with P<0.05 are highlighted in bold font.

a Linear regressions of log2anti-HIV antibody levels. Note: outcome measures are shown in the rows in the left column while predictor variables are shown in columns.

b Fold-change in anti-HIV antibody responses per two fold-change in the HIV reservoir measure.

c Bonferroni-adjusted significance cutoff would be P < 0.00045, after adjustment for 112 assessments of association.